<?xml version="1.0" encoding="UTF-8"?>
<p>SARS-CoV-2 shares an 80% RNA sequence homology with the acute respiratory syndrome-associated coronavirus (SARS-CoV).
 <xref rid="cit0002" ref-type="bibr">2</xref>,
 <xref rid="cit0003" ref-type="bibr">3</xref> Some enzymes of both viruses show more than 90% sequence homology.
 <xref rid="cit0002" ref-type="bibr">2</xref> For example, RNA-dependent RNA polymerase (RdRp) of both coronaviruses shares 96% sequence similarity.
 <xref rid="cit0002" ref-type="bibr">2</xref> Accordingly, existing drugs against SARS-CoV and Middle East Respiratory Syndrome coronavirus (MERS-CoV) may be also useful to fight COVID-19.
 <xref rid="cit0001" ref-type="bibr">1</xref>,
 <xref rid="cit0003" ref-type="bibr">3</xref>
</p>
